VitaNova Life Sciences (VNOV) Notes Payables (2017)
VitaNova Life Sciences (VNOV) reported Notes Payables of $6000.0 for Q2 2017.
VitaNova Life Sciences (VNOV) Notes Payables (2017) Analysis & Trends
VitaNova Life Sciences has reported Notes Payables for 1 years, with the latest figure at $6000.0 in Q2 2017.
- For the quarter ending Q2 2017, Notes Payables changed N/A year-over-year to $6000.0; the trailing twelve-month figure through Apr 2017 stood at $6000.0 (changed N/A YoY), and the FY2017 full-year result was $6000.0, changed N/A from the prior year.
- Notes Payables for Q2 2017 stood at $6000.0.
- The five-year high for Notes Payables was $6000.0 in Q2 2017, with the low at $6000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2017 | 6,000.00 |